CLAREMONT BIOSOLUTIONS LLC
Automated cartridge system for high-molecular-weight DNA and RNA extraction optimized for long-read sequencing
- Sector
- Biotech
- Headquarters
- Upland, CA
- Total capital
- $5.2M
- Federal grants
- $5.1M
- 7 awards · 2015–2022
- Rank in peer group#38 of 42
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $111K
- 5 awards · Health and Human S, Interior, NASA
- Rank in Biotech#323 of 4373
- Granted patents
- 8
- 4 pending · first 2016
- Rank in peer group#4 of 42
Capital timeline
Latest events
- Federal contractNASA · Dna Extraction Instrument$16K
- Federal contractNASA · Mold Design And Fabrication To Incorporate A Larger Lysis Chamber And Liquid Storage Reservoirs$40K
- Federal grantHealth and Human S · Phase II · Automated Ultra-Long DNA and RNA Extraction for Long-read Sequencing Applications$868K
- Federal contractNASA · This Purchase Order Is For Microbial Cell Lysis Device For One Liner Scale Cultures, 210427NASA, 04/27/2021...LEAD Time For Delivery: 5 Weeks From Initiating Contract Award.$41K
- Federal grantHealth and Human S · Phase II · Automated Ultra-Long DNA and RNA Extraction for Long-read Sequencing Applications$2M
- Federal grantHealth and Human S · Phase II · Automated Ultra-Long DNA and RNA Extraction for Long-read Sequencing Applications$1.2M
- Federal grantHealth and Human S · Phase I · Rapid sample preparation method for high molecular weight DNA from tumor tissues suitable for structural variant analysis$300K
Show 5 earlier federal awards
- Federal grantHealth and Human S · Phase I · A novel ultra-long DNA extraction technology for long-read genomic applications$197K
- Federal grantHealth and Human S · Phase I · A novel ultra-long DNA extraction technology for long-read genomic applications$197K
- Federal contractInterior · Lateral Dispenser And Supplies "igf::ot::igf"$7K
- Federal grantHealth and Human S · Phase I · Automated High-throughput Platform for Tissue Homogenization and RNA Extraction$342K
- Federal contractHealth and Human S · Igf::ot::igf-reagent Dispenser$7K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 42 peers
Line = medianBiotech · Instrument
- Federal grantsBelow median
- Granted patents#4 · top 10%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 8 granted of 12- GrantedCompositions And Methods For Disaggregation Of Biological Tissue SamplesUSPTOUS 11,718,817
- GrantedArrayed Lyser And Homogenizer Systems With Multiple Agitator DevicesUSPTOUS 11,479,747
- GrantedSystem, Apparatus And Method For Material Preparation And/or HandlingUSPTOUS 11,473,049
Show all 12 patent records
- Compositions And Methods For Disaggregation Of Biological Tissue SamplesAug 8, 2023 · US 11,718,817Granted
- Arrayed Lyser And Homogenizer Systems With Multiple Agitator DevicesOct 25, 2022 · US 11,479,747Granted
- System, Apparatus And Method For Material Preparation And/or HandlingOct 18, 2022 · US 11,473,049Granted
- Compositions And Methods For Disaggregation Of Biological Tissue SamplesMar 29, 2022 · US 11,286,447Granted
- Compositions And Methods For Disaggregation Of Biological Tissue SamplesOct 13, 2020 · US 10,801,001Granted
- Homogenizer RackSep 25, 2018 · US D,829,339Granted
- Capture And Elution Of Bio-analytes Via Beads That Are Used To Disrupt SpecimensJan 23, 2018 · US 9,873,860Granted
- Compositions And Methods For Capture And Elution Of Biological Materials Via ParticulatesAug 30, 2016 · US 9,428,725Granted
- Capture And Elution Of Bio-analytes Via Beads That Are Used To Disrupt SpecimensApplication PCTUS2010039872Pending
- Arrayed Lyser And Homogenizer Systems With Multiple Agitator DevicesApplication PCTUS2018016442Pending
- Arrayed Lyser And Homogenizer Systems With Multiple Agitator DevicesApplication 62454500Pending
- Compositions And Methods For Disaggregation Of Biological Tissue SamplesApplication PCTUS2016027291Pending
Related companies, and why
- ONCTERNAL THERAPEUTICS, INC.Similar federal contract value in Biotech · $116K in contracts
- Advanced Targeting SystemsSimilar federal contract value in Biotech · $114K in contracts
- Arrayit CorpSimilar federal contract value in Biotech · $114K in contracts
- ChemocentryxSimilar federal contract value in Biotech · $107K in contracts
- SeromYx Systems, Inc.Similar federal contract value in Biotech · $107K in contracts
- Xona Microfluidics, Inc.Similar federal contract value in Biotech · $104K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .